NCT05325996Completed
Evaluating Home Testing Devices for the Management of Glaucoma
Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.
Source: ClinicalTrials.gov · Last updated 20 Aug 2026
Brief summary (registry, in English)
With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 53 (actual)
- First submitted
- 25 Mar 2022
- Start date
- 15 Apr 2022
- Primary completion date
- 17 Aug 2026
- Lead sponsor
- Wills Eye
- Diseases
- Glaucoma
- NCT number
- NCT05325996
What you commit to
- Study type: Interventional
- Participants enrolled: 53
- From 15 Apr 2022 to the primary completion date, 17 Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment
- Filtering surgeries less than 6 months prior to enrollment
- Intraocular surgery other than:
- Non-complicated MIGS more than 90 days prior to enrollment;
- Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification
- Other glaucoma surgery more than 6 months prior to enrollment.
Other illness
- History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function.
- History of medication known to affect visual function or influence patient reaction time
Other
- Spherical refraction outside \> ± 12.00 D and cylinder correction \> +2.5 D.
- Visual acuity worse than 20/50 either eye
- Inability to use device after remote training session
- Subjects unwilling and/or unable to participate
Who the study is looking for
- Age 20-80 years
- Mild and Moderate Open Angle Glaucoma (OAG)
- Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter.
Age in the registry: 20 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Wills Eye Hospital Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.